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Hepcidin,akeyregulatorofironmetabolism,isactivatedbybonemorphogeneticproteins(BMPs).Micepair-fedwithregularand
ethanol-containing L. De Carli diets were employed to study the eﬀect of alcohol on BMP signaling and hepcidin transcription in
the liver. Alcohol induced steatosis and TGF-beta expression. Liver BMP2, but not BMP4 or BMP6, expression was signiﬁcantly
elevated. Despite increased BMP expression, the BMP receptor, and transcription factors, Smad1 and Smad5, were not activated.
In contrast, alcohol stimulated Smad2 phosphorylation. However, Smad4 DNA-binding activity and the binding of Smad4 to
hepcidin promoter were attenuated. In summary, alcohol stimulates TGF-beta and BMP2 expression, and Smad2 phosphorylation
but inhibits BMP receptor, and Smad1 and Smad5 activation. Smad signaling pathway in the liver may therefore be involved
in the regulation of hepcidin transcription and iron metabolism by alcohol. These ﬁndings may help to further understand the
mechanisms of alcohol and iron-induced liver injury.
1.Introduction
Alcoholic liver-disease patients frequently display evidence
of iron overload [1–5]. Alcohol-induced iron overload
enhances the production of free radicals and proinﬂamma-
tory cytokines [6, 7]. However, the underlying mechanisms
of iron accumulation observed in alcoholic liver disease
are unclear. We and others have recently shown a role
for hepcidin in alcohol-induced increases in iron transport
[8–13]. Hepcidin is a circulatory antimicrobial peptide
synthesized by the liver [14, 15]. It plays a pivotal role in
iron homeostasis by inhibiting iron uptake in the duodenum
and iron export in reticuloendothelial macrophages [16,
17]. Alcohol downregulates hepcidin expression in the liver,
which leads to an increase in duodenal iron transporter
expression [9]. However, how alcohol suppresses hepcidin
transcription in the liver is still unclear.
Bone morphogenetic proteins (BMPs) belong to the
transforming growth factor beta (TGF-β), superfamily of
growth factors [18]. BMP2, BMP4, BMP6 and BMP9
have all been reported to regulate hepcidin transcription
[19–22]. However, transgenic mouse studies have recently
suggested that BMP6, is involved in the regulation of
hepcidin expression in vivo [23, 24]. Moreover, iron has
been shown to induce BMP6 mRNA expression and Smad5
phosphorylation [25–27] .S i m i l a rt oT G F - β receptor, the
binding of BMP ligands to type I and type II BMP receptor
serine/threonine kinases leads to the phosphorylation and
activation of type I BMP receptor (BMPR-I) [28]. Activated
BMPR-I in turn phosphorylates the receptor-regulated Smad
(R-Smad) family of transcription factors: Smad1, Smad5,
and Smad8 [29]. On the other hand, activated TGF-β
receptor induces the phosphorylation of Smad2 and Smad3.
Upon phosphorylation, these R-Smads form a complex with
the common mediator of Smad signaling, Smad4. The Smad
complexes subsequently translocate into the nucleus where
they participate in the regulation of gene transcription [30,
31]. Of note, liver-speciﬁc disruption of Smad4 leads to2 International Journal of Hepatology
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Figure 1: Liver Histology. The ﬁxed liver sections of mice fed with regular (a) or ethanol-containing (b) Lieber-De Carli liquid diets were
stained with hematoxylin and eosin (a, b), as described in Materials and Methods (original magniﬁcation 20X). The arrows indicate steatosis
(b).
a decrease in hepcidin expression and accumulation of iron
in liver, kidney, and pancreas [32].
The involvement of the proﬁbrogenic cytokine, TGF-
β in alcohol-induced liver injury has been well-established
[33, 34]. However, the role of BMPs and BMP receptor-
mediated signaling in alcoholic liver disease is largely
unknown. In this study, we examine the eﬀect of alcohol on
BMP expression and BMP receptor-mediated regulation of
hepcidin transcription in the liver in vivo. Alcohol and iron
play a synergistic role in the pathogenesis of alcoholic liver
disease. These studies will help us to further understand the
mechanisms of liver injury induced by iron and alcohol.
2.MaterialsandMethods
2.1. Animal Experiments. Animal experiments were ap-
proved by the Animal Ethics Committee at the University of
Nebraska Medical Center. C57BL/6 NCR male mice (NIH)
were housed individually and pair-fed with either regular
or ethanol-containing Lieber De Carli liquid diets (Dyets,
Inc., cat no: 710027, 710260, resp.), as described previously
[12]. The ethanol content of the diet was gradually increased
over a 9-day period to 5% (no ethanol for 3 days, 1% for 2
d a y s ,2 %f o r2d a y s ,a n d3 %f o r2d a y s ) .M i c ew e r ee x p o s e d
to 5% ethanol for 4 weeks. For iron experiments, mice
were fed initially with a custom prepared egg-white-based
solid rodent diet [35] containing 0.02% carbonyl iron (F614,
Bio-Serv, Inc.) for one week to achieve a basal hepcidin
expression level. Subsequently, they were fed with 0.2% or
2% carbonyl iron diets for 3 weeks to achieve normal and
iron overload states, respectively, as published previously
[12].
2.2. RNA Isolation, cDNA Synthesis, and Real-Time Quan-
titative PCR Analysis. RNA isolation, cDNA synthesis, and
quantitative PCR were performed, as published previously
[9]. The sequences of Taqman ﬂuorescent probe (5
  6-
[FAM]; 3
  [TAMRA-Q]) and primers are shown in Table 1.
2.3. Western Blotting, Immunoprecipitation, and Immuno-
histochemistry. Total liver cell lysates were prepared by
homogenizing mouse livers in lysis buﬀer [10mM Tris/HCl
(pH 7.4), 100mM NaCl, 5mM EDTA, 10% glycerol, 1mM
PMSF, complete protease inhibitor cocktail (Roche Diag-
nostics Corp.), phosphatase inhibitor cocktail A (Santa
Cruz, sc-45044), and 1% Triton-X-100]. The lysates were
subsequently incubated on ice for 20min. and centrifuged
(3000xg) for 5min. at 4◦C. Supernatants were employed for
western blot or immunoprecipitation experiments. Western
b l o t sw e r ep e r f o r m e d ,a sd e s c r i b e dp r e v i o u s l y[ 12, 36].
Anti-phospho-Smad2, anti-phosho-Smad1/5, anti-Smad2,
and anti-Smad5 antibodies were obtained commercially (cell
signaling). For immunoprecipitations, 500μgo fl i v e rl y s a t e
protein was incubated with BMPR-I antibody or normal
rabbit IgG (Santa Cruz) and protein A/G PLUS-Agarose pre-
blocked with BSA (Santa Cruz). Immunocomplexes eluted
by nonreducing SDS buﬀer were resolved on 10% polyacry-
lamide gels and immunoblotted with anti-phosphoserine
(Millipore) or BMPR-I antibodies (Santa Cruz). Alkaline
phosphatase-conjugated anti-mouse (Millipore) or anti-
rabbit (SouthernBiotech) light chain-speciﬁc immunoglob-
ulins were used as secondary antibodies. Immunostaining
of paraﬃn embedded liver sections with TGF-β (Abcam) or
BMP2(SantoCruz)antibodieswereperformedbyVectastain
ABC kit (Vector Labs), according to manufacturer’s instruc-
tions.
2.4. Electrophoretic Mobility Gelshift Assay (EMSA). Mouse
liver nuclear lysate isolation and EMSA were performed,
as described [9]. Brieﬂy, the consensus and mutant Smad4
oligonucleotides (Santa Cruz) were labeled by T4 polynu-
cleotide kinase and 32P-γ-ATP (Perkin Elmer, 3.000Ci/moL,
10mCi/mL).7μgofnuclearextractproteinand100.000cpm
of 32P-labeled Smad probes were used for each binding
reaction. Protein and DNA complexes were resolved on
7% nondenaturing polyacrylamide gels and radiolabeled
bands were visualized by autoradiography. For competition
assays, unlabeled consensus Smad oligonucleotide in 30-
fold excess was incubated with nuclear lysates on ice
prior to the addition of the 32P-labeled consensus Smad
probe.International Journal of Hepatology 3
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Figure 2: TGF-β Expression. The ﬁxed liver sections of mice fed with regular (a) or ethanol-containing (b) Lieber-De Carli liquid diets were
immunostained with an anti-TGF-β antibody, as described in Materials and Methods. Liver sections from mice injected (i.p.) with sunﬂower
oil,ascontrol(c)orcarbontetrachloride(d)for8weekswerealsoimmunostainedwiththeanti-TGF-β antibodytoserveaspositivecontrols
for TGF-β staining. The arrows indicate TGF-β expression (b, d) (original magniﬁcation 20X). Whole cell lysates isolated from the livers of
mice fed with regular (control) or ethanol-containing (alcohol) Lieber-De Carli liquid diets were employed to determine TGF-β protein
expression by western blotting, as described in Materials and Methods (e). An anti-gapdh antibody was employed to conﬁrm equal protein
loading (f). TGF-β protein expression, normalized to gapdh, in alcohol-treated mice was expressed as fold expression of that in control mice
and was quantiﬁed by scanning autoradiographs by a densitometer (g).4 International Journal of Hepatology
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Figure 3: Smad2 Activation. The phosphorylation of Smad2 protein in the liver lysates of mice fed with regular (control) or ethanol-
containing (alcohol) Lieber-De Carli liquid diets was determined by western blotting employing an anti-phospho-Smad2 antibody, as
described in Materials and Methods. (b) An antibody recognizing the total levels of Smad2 protein was employed as a control to conﬁrm
equal protein loading. (c) Autoradiographs from diﬀerent experiments (n = 3) were scanned by a densitometer, and phospho-Smad2 (p-
Smad2)expressionineachsamplewasquantiﬁedbynormalizingtototalSmad2proteinexpression.Normalizedphospho-Smad2expression
in alcohol-treated mice was expressed as fold expression of that in control mice.
Table 1: Mouse-speciﬁc sequences of real-time quantitative PCR probe and primers.
Gene Forward primer (5
 -3
 ) Reverse primer (5
 -3
 )T a q m a n p r o b e ( 5
 -3
 )
BMP2 GCATCCAGCCGACCCTT GCCTCAACTCAAATTCGCTGA TCCCGGCCTTCGGAAGACGTC
BMP4 GGACTTCGAGGCGACACTTC TTGCTAGGCTGCGGACG ACAGATGTTTGGGCTGCGCCG
BMP6 CCTCTTCTTCGGGCTTCCTC CCTTTTGCATCTCCCGCTT ATCGGCGGCTCAAGACCCACG
Hepcidin ACTCGGACCCAGGCTGC AGATAGGTGGTGCTGCTCAGG TGTCTCCTGCTTCTCCTCCTTGCCA
2.5. Chromatin Immunoprecipitation (CHIP). CHIP was
performed, as described [37]. Chromatin isolated from
formalin-ﬁxed mouse liver was sheared by sonication and
immunoprecipitated by using control IgG (cell signaling) or
anti-Smad4 antibody (cell signaling) and protein A/G beads
(Santa Cruz). An aliquot of precleared chromatin was saved
astotalinputDNApriortotheimmunoprecipitation. Coim-
munoprecipitated DNA and total input DNA were analyzed
by PCR using primers (forward 5
 -gccatactgaaggcactga
 3;
reverse 5
 -gtgtggtggctgtctagg-3
 ) speciﬁc for mouse hepcidin
promoter.
2.6. Statistical Analysis. Statistical analysis of diﬀerences in
treatmentgroupswasperformedbyusingthenonparametric
Mann-Whitney test and Student’s t-test.
3. Results
I no r d e rt os t u d yt h ee ﬀect of chronic alcohol consumption
on the expression of diﬀerent bone morphogenetic proteins
(BMPs) and signaling in the liver, we employed wild-type
mice pair-fed with regular (control) or ethanol-containing
Lieber De Carli diets, as described in Materials and Methods.
Mice fed with alcohol for 4 weeks displayed signiﬁcant lipid
accumulation in the liver, compared to control mice fed
with regular L. De Carli diet, as shown by hematoxylin and
eosin staining (Figures 1(a) and 1(b)). Similarly, chronic
alcohol consumption resulted in increased transforming
growth factor beta (TGF-β) expression in the liver, as shown
by immunostaining and western blotting (Figure 2). TGF-β
is known to induce the phosphorylation and activation of
the transcription factor, Smad2 [29]. Accordingly, western
blot analysis indicated a signiﬁcant twofold increase in the
level of phospho-Smad2 protein expression in the livers of
alcohol-fed mice compared to control mice (Figures 3(a)
and 3(c)). The level of total Smad2 protein expression in
the liver was not altered by alcohol (Figure 3(b)). BMPs
also belong to the TGF-β superfamily of growth factors and
activatetheSmadsignalingpathway[18].However,theeﬀectInternational Journal of Hepatology 5
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Figure 4: Alcohol and BMP2, BMP4, BMP6 Expression. (a) cDNA was synthesized from liver RNA of mice fed with regular (control) or
ethanol-containing (alcohol) Lieber-De Carli liquid diets, as described in Materials and Methods. It was employed in real-time PCR to
detect bone morphogenetic protein (BMP) expression. The mRNA expression in alcohol-fed mice was expressed as fold of that in pair-fed
control mice fed with regular diet (mean ± S.E.M.; n = 3, 4 mice per group). Asterisks indicate statistical signiﬁcance (P< 0.05). The ﬁxed
liver sections of mice fed with regular (b) or ethanol-containing (c) Lieber-De Carli liquid diets were immunostained with an anti-BMP2
antibody, as described in Materials and Methods. The arrows indicate BMP2 expression (original magniﬁcation 20X).
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Figure 5: Alcohol and Hepcidin Expression. cDNA was synthesized from liver RNA of mice fed with regular (control) or ethanol-containing
(alcohol)Lieber-DeCarliliquiddiets,asdescribedinMaterialsandMethods.Itwasemployedinreal-timePCRtodetecthepcidinexpression.
ThemRNAexpressioninalcohol-fedmicewasexpressedas-foldofthatinpair-fedcontrolmicefedwithregulardiet(mean ±S.E.M.;n = 3,
4 mice per group). Asterisks indicate statistical signiﬁcance (P< 0.05).6 International Journal of Hepatology
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Figure 6: Activation of Smad1 and Smad5. (a) The phosphorylation of Smad1 and Smad5 proteins in the liver lysates of mice fed with
regular (control) or ethanol-containing (alcohol) Lieber-De Carli liquid diets, and of mice fed with diets containing 0.2% (normal) or 2%
(overload) carbonyl iron was determined by western blotting employing an anti-phospho-Smad1/5 antibody, as described in Materials and
Methods. (b) An antibody recognizing the total levels of Smad5 protein was employed as a control to conﬁrm equal protein loading. (c)
Autoradiographs from diﬀerent experiments (n = 3) were scanned by a densitometer, and phospho-Smad1/5 (p-Smad5) expression in each
sample was quantiﬁed by normalizing to total Smad5 protein expression. Normalized phospho-Smad expression in alcohol or iron-fed mice
was expressed as fold expression of that in the control mice.
of alcohol on BMP expression is unknown. Compared to
control mice, mice with chronic alcohol exposure displayed
an increase in BMP2, BMP4, and BMP6 mRNA expression
in the liver (Figure 4(a)). However, the median response
diﬀerences in BMP4 and BMP6 expression between alcohol-
fed and control mice were not statistically signiﬁcant (P>
0.05) (Figure 4(a)). In contrast, the alcohol-induced increase
in BMP2 mRNA expression in the liver was statistically
signiﬁcant (P< 0.05) (Figure 4(a)) .T h el i v e r so fa l c o h o l -
treated mice also exhibited an increase in BMP2 protein
expressioncomparedtocontrolmice(Figures4(b)and4(c)).
Mice with chronic alcohol exposure displayed a signiﬁcant
(P<0.05)decreaseinhepcidinmRNAexpressionintheliver
(Figure 5).
Bone morphogenetic proteins induce intracellular sig-
naling via the phosphorylation of the transcription factors,
Smad1, Smad5, and Smad8. We performed western blots
by using an antibody which recognizes both Smad1 and
Smad5 phosphorylated on serine residues, as described in
Materials and Methods. Unlike Smad 2 (see above), our
westernblotanalysisdidnotdetectasigniﬁcantchangeinthe
phosphorylation of Smad1 and Smad5 proteins in the livers
of alcohol-treated mice, compared to the controls (Figures
6(a) and 6(c)). Since iron has been reported to induce BMP
signaling and Smad5 phosphorylation [25, 27], the livers of
mice fed with iron diets (see Materials and Methods) were
employed as internal controls. Accordingly, our western blot
analysis detected a signiﬁcant increase in Smad1 and Smad5
phosphorylation in the livers of mice with iron overload,
compared to control mice with a normal iron state (Figures
6(a) and 6(c)). The level of total Smad5 protein expression
in the liver was not altered by alcohol or iron treatments
(Figure 6(b)).
Bonemorphogeneticproteinsbindtoandsignalthrough
type I and type II serine/threonine kinase receptors, BMPR-
I and BMPR-II. Upon ligand binding, BMPR-I is phos-
phorylated. To determine the activation of BMPR-I, we
performed immunoprecipitation experiments followed by
western blotting, as described in Materials and Methods.
BMPR-I immunocomplexes from mouse livers were blotted
with an anti-phosphoserine antibody. The level of BMPR-
I phosphorylation on serine residues in alcohol-fed mice
was not signiﬁcantly diﬀerent than that in control mice
(Figures 7(a) and 7(c)). However, BMPR-I phosphorylationInternational Journal of Hepatology 7
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Figure 7: Activation of BMPR-I. Bone morphogenetic protein receptor type I (BMPR-I) was immunoprecipitated from the liver lysates of
mice fed with regular (control) or ethanol-containing (alcohol) Lieber-De Carli liquid diets, and of mice fed with diets containing 0.2%
(normal) or 2% (overload) carbonyl iron, as described in Materials and Methods. The phosphorylation of BMPR-I on serine residues
in the immune complexes was determined by western blotting employing an anti-phosphoserine antibody (a), and the total levels of
BMPR-I protein were detected by western blotting with an anti-BMPR-I antibody (b). (c) Autoradiographs from diﬀerent experiments
(n = 2) were scanned by a densitometer, and phospho-BMPR-I (p-BMPR-I) expression in each sample was quantiﬁed by normalizing
to immunoprecipitated BMPR-I protein level. Normalized p-BMPR-I expression in alcohol or high iron-fed mice was expressed as fold
expression of that in the control mice or in mice fed with normal iron diet.
was induced in the livers of mice fed with high iron
diets, which were used as internal controls (Figures 7(a)
and 7(c)). We also conﬁrmed by western blotting that
equal levels of BMPR-I protein were immunoprecipitated
from the livers of alcohol or iron-treated and control mice
(Figure 7(b)). Furthermore, control samples, which were
immunoprecipitated with normal rabbit IgG also showed no
signiﬁcant BMPR-I phosphorylation (Figure 7(a)).
Smad4 forms a complex with phosphorylated R-Smads
and regulates the transcription of target genes. In order
to determine the eﬀect of alcohol on Smad4 DNA-binding
activity in the liver, we performed electromobility shift
assays, as described in Materials and Methods. The DNA-
binding activity of Smad4 in liver nuclear lysates from mice
with chronic alcohol exposure was not signiﬁcantly diﬀerent
than that of control mice (Figure 8). However, iron, used
as internal control, induced Smad DNA-binding activity
(Figure 8). The speciﬁcity of DNA-binding activity was also
conﬁrmed with both competition tests, using unlabeled
(cold) Smad consensus oligonucleotides, and by employing
32P-labeled mutant Smad oligonucleotide as a probe in
gelshift assays, as described in Materials and Methods
(Figure 8).
In order to determine the eﬀect of chronic alcohol
exposure on Smad4-mediated transcription of hepcidin, we
performed chromatin immunoprecipitation experiments, as
described in Materials and Methods. The binding of Smad4
to hepcidin promoter was signiﬁcantly attenuated in the
livers of mice treated with alcohol compared to control
mice (Figures 9(a) and 9(d)). We have also conﬁrmed that
the level of total input DNA (see Materials and Methods)
was similar in all samples (Figure 9(b)). Furthermore, no
signiﬁcant ampliﬁcation of hepcidin promoter was observed
in chromatin samples, which were immunoprecipitated with
the control IgG (Figure 9(c)).
4. Discussion
Hepcidin, mainly synthesized in the liver, is the key regulator
of iron homeostasis and its expression is also regulated by
iron. Alcohol has been shown to suppress hepcidin tran-
scription in the liver leading to elevated iron absorption in8 International Journal of Hepatology
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Figure 8: Smad4 DNA-Binding Activity. Smad DNA-binding activity was determined by electrophoretic mobility gelshift assays (EMSA),
as described in Materials and Methods. 7μg of nuclear lysate protein isolated from the livers of mice fed with regular (control) or ethanol-
containing (alcohol) Lieber-De Carli liquid diets, and of mice fed with diets containing 0.2% (normal) or 2% (overload) carbonyl iron was
employed in EMSA. Cold competition with unlabeled Smad consensus (cons.) oligonucleotides and 32P-labeled mutant Smad probe were
employed to test the speciﬁcity of DNA binding, as described in Materials and Methods. The arrows indicate speciﬁc Smad DNA complexes
and unbound (free) probes. The results are representative of multiple EMSA experiments (n = 3).
the duodenum [9–11, 13]. However, how alcohol attenuates
liver hepcidin transcription and function is not completely
understood.
Various signaling mechanisms including BMP-mediated
Smad signaling are involved in the regulation of hepcidin
transcription in the liver [23–25, 27]. The deletion of Smad4
in the liver also attenuates hepcidin expression and causes
pronounced hepatic iron accumulation in mice [32]. BMPs
belong to the TGF-β superfamily of growth factors. TGF-β is
one of the main proﬁbrogenic cytokines, which is involved
in the progression of alcoholic liver disease [33, 34, 38].
However, the role of BMPs in alcoholic liver disease is
unclear. Here, we show that alcohol signiﬁcantly induces the
expression of BMP2 in the liver in vivo. Although alcohol
is known to alter iron homeostasis [3, 5, 39], unlike iron
[25, 27], chronic alcohol exposure did not signiﬁcantly
upregulate the expression of BMP6 in the liver.
Ligand binding induces the phosphorylation of type I
BMP receptor (BMPR-I). Upon phosphorylation, BMPR-
I stimulates BMP signaling by phosphorylating Smad1,
Smad5,andSmad8.Interestingly,despiteanalcohol-induced
increase in BMP expression, the phosphorylation of Smad1
and Smad5 was not elevated in the livers of mice with
chronic alcohol exposure. In contrast, TGF-β-mediated
phosphorylation of Smad2 was induced by alcohol. BMPR-
I receptor is expressed on the plasma membrane. It is feasible
that alcohol-mediated inhibition of BMP-mediated Smad
signaling may occur in proximity to the cell surface. Our
immunoprecipitation studies clearly demonstrate a lack of
BMPR-I phosphorylation in the livers of mice with chronic
alcohol exposure. The speciﬁcity of immune complexes was
conﬁrmed by employing control antibodies and IgG light-
chain-speciﬁc secondary antibodies for western blotting (see
Figure 7). Furthermore, we have also conﬁrmed that iron, as
an internal control, upregulates the phosphorylation of both
BMPR-I, and Smad1 and Smad5 proteins. Of note, we have
previously reported that alcohol renders hepcidin insensitive
to body iron levels and abolishes its protective role in iron
overload [12]. However, whether or not alcohol interferes
with iron-mediated activation of hepcidin transcription via
BMP/Smad signaling in the liver warrants further investiga-
tion.
The inhibition of BMP receptor activation and signal-
ing by alcohol may involve various mechanisms. Alcohol
metabolism is well known to increase the NADH:NAD+
ratio and induce hypoxia in the liver. Accordingly, hypoxia
has recently been suggested to inhibit hepcidin expression
by attenuating Smad signaling in human Huh7 hepatoma
cells [40]. Furthermore, hypoxia-induced changes in the
NADH:NAD+ r a t i oh a v eb e e nr e p o r t e dt oa t t e n u a t eB M P
receptor activation in lung cells [41]. However, it should
be noted that alcohol-induced hypoxia is limited to theInternational Journal of Hepatology 9
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Figure 9: Smad4 Binding to Mouse Hepcidin Promoter.C h r o -
matin was isolated from the livers of mice fed with regular
(control) or ethanol-containing (alcohol) Lieber-De Carli liquid
diets. Chromatin immunoprecipitation was performed with anti-
Smad4 antibody (a) or normal rabbit IgG (control) (c). The
coimmunoprecipitated DNA and total input DNA (control) (b)
were subjected to PCR to amplify a 321 base pair mouse hepcidin
promoter region, as described in Materials and Methods. (d)
Ethidium bromide-stained agarose gels from diﬀerent experiments
(n = 3) were scanned to quantify the amount of Smad4 co-
immunoprecipitated DNA by normalizing to input DNA.
centrilobular region of the liver [42]. It is therefore possible
that other mechanisms besides hypoxia may be involved in
alcohol-induced inhibition of BMP-mediated Smad signal-
ing in the liver. For example, changes in inhibitory Smads
or a competition between R-Smads activated by TGF-β
(Smad2, Smad3) and BMPs (Smad1, Smad5, and Smad8).
Of note, TGF-β receptor has been reported to interact with
BMPR-I and inhibit BMP-mediated Smad signaling [43].
Accordingly, we have observed the activation of Smad2,
but not of Smad1 or Smad5, in the livers of mice with
chronic alcohol exposure. Conversely, recombinant BMP6
has been shown to inhibit TGF-β-mediated Smad signaling
[44]. Nevertheless, our ﬁndings showing alcohol-induced
inhibition of Smad DNA-binding activity and the binding of
Smad4 to hepcidin promoter strongly suggest that alcohol
can directly interfere with nuclear Smad DNA complexes.
The regulation of Smad signaling complexes by alcohol
may therefore be one of the mechanisms by which alcohol
suppresses hepcidin transcription in the liver in vivo.
Alcohol metabolism in the liver produces toxic metabo-
lites, such as acetaldehyde and lipid peroxidation products
[45, 46]. They, in turn, activate TGF-β production and
lead to the secretion of extracellular matrix proteins [33].
BMPs have been reported to interact with and antagonize
TGF-β blocking its proﬁbrogenic activity [47, 48]. By
blocking TGF-β, BMPs can also modulate cell adhesion and
migration [49, 50]. It is therefore possible that the induction
of BMP expression in the liver in response to chronic
alcohol exposure is associated with antiﬁbrogenic response
mechanisms. Furthermore, the inverse eﬀect of alcohol on
TGF-β and BMP-mediated Smad signaling may be one of the
mechanisms involved in the progression of liver ﬁbrosis in
alcoholic liver disease.
The alcohol-induced inhibition of Smad4 binding to
hepcidin promoter and suppression of hepcidin transcrip-
tion in the liver is expected to gradually elevate intestinal
i r o nu p t a k ea n di r o ns t o r a g ei nK u p ﬀer cells. Accordingly,
we have previously reported the elevation of hepatic iron
levels in rats with chronic alcohol exposure [12]. Iron and
alcohol are known to act synergistically to induce liver
injury[51–53].Interestingly,theinhibitionofBMPsignaling
has also been reported in Hfe knockout mice, an animal
model for the commonest iron overload disorder, genetic
hemochromatosis [54, 55]. This study therefore indicates a
role for Smad signaling in the regulation of iron metabolism
by alcohol, which may have implications for alcoholic liver
disease and also genetic hemochromatosis in conjunction
with alcohol.
5. Conclusions
Bone morphogenetic protein signaling has recently been
shown to induce hepcidin transcription in the liver. BMP
and TGF-β both belong to the same family of growth
factors and stimulate the Smad signaling pathway. Alcohol
is known to induce TGF-β expression, which plays a role in
liver ﬁbrinogenesis, whereas the eﬀect of alcohol on BMP
signaling is unknown. Here, we show that similar to TGF-
β, BMP protein expression was also upregulated in the
liver. However, alcohol exerted diﬀerent eﬀects on TGF-
β-mediated Smad2 activation and BMP-mediated Smad1
and Smad5 activation. The inhibitory eﬀect of alcohol on
BMP-mediated Smad signaling may occur in proximity to
the cell surface by interfering with the activation of BMP
receptor type I. This subsequently resulted in the inhibition
of Smad4 binding to hepcidin promoter in the livers of10 International Journal of Hepatology
mice with chronic alcohol exposure. Collectively, these
ﬁndings strongly suggest that the simultaneous inhibition of
BMP-mediated Smad activation and stimulation of TGF-β-
mediated Smad activation by alcohol may be involved in the
suppression of liver hepcidin transcription and deregulation
of iron metabolism by alcohol in vivo.I r o na n da l c o h o la c t
synergistically to induce liver injury. Further understanding
of the role of alcohol in Smad signaling and hepcidin
transcription will help to elucidate the mechanisms of liver
injury observed in patients with alcoholic liver disease or
with genetic hemochromatosis and alcohol abuse.
Acknowledgments
The authors thank Dr. Robert G. Bennett (Omaha VA
Medical Center) for providing the livers from mice treated
with carbon tetrachloride. These studies were supported by
funds from the University of Nebraska Medical Center and
R01 Grant (AA017738) to D. Harrison-Findik.
References
[1] J. B. Whitﬁeld, G. Zhu, A. C. Heath, L. W. Powell, and N.
G. Martin, “Eﬀects of alcohol consumption on indices of
iron stores and of iron stores on alcohol intake markers,”
Alcoholism: Clinical and Experimental Research, vol. 25, no. 7,
pp. 1037–1045, 2001.
[ 2 ]M .G .I r v i n g ,J .W .H a l l i d a y ,a n dL .W .P o w e l l ,“ A s s o c i a t i o n
between alcoholism and increased hepatic iron stores,” Alco-
holism: Clinical and Experimental Research, vol. 12, no. 1, pp.
7–13, 1988.
[3] G. N. Ioannou, J. A. Dominitz, N. S. Weiss, P. J. Heagerty,
a n dK .V .K o w d l e y ,“ T h ee ﬀect of alcohol consumption on
the prevalence of iron overload, iron deﬁciency, and iron
deﬁciencyanemia,”Gastroenterology,vol.126,no.5,pp.1293–
1301, 2004.
[4] A. S. Tavill and A. M. Qadri, “Alcohol and iron,” Seminars in
Liver Disease, vol. 24, no. 3, pp. 317–325, 2004.
[5] P. Duane, K. B. Raja, R. J. Simpson, and T. J. Peters, “Intestinal
iron absorption in chronic alcoholics,” Alcoholand Alcoholism,
vol. 27, no. 5, pp. 539–544, 1992.
[6] L. G. Valerio, T. Parks, and D. R. Petersen, “Alcohol mediates
increases in hepatic and serum nonheme iron stores in a rat
model for alcohol-induced liver injury,” Alcoholism: Clinical
andExperimentalResearch,vol.20,no.8,pp.1352–1361,1996.
[7] M. Lin, R. A. Rippe, O. Niemela, G. Brittenham, and H.
Tsukamoto, “Role of iron in NF-kappa B activation and
cytokine gene expression by rat hepatic macrophages,” The
American Journal of Physiology, vol. 272, pp. G1355–G1364,
1997.
[8] D. D. Harrison-Findik, “Is the iron regulatory hormone
hepcidin a risk factor for alcoholic liver disease?” World
Journal of Gastroenterology, vol. 15, no. 10, pp. 1186–1193,
2009.
[9] D. D. Harrison-Findik, D. Schafer, E. Klein et al., “Alcohol
metabolism-mediated oxidative stress down-regulates hep-
cidin transcription and leads to increased duodenal iron
transporter expression,” Journal of Biological Chemistry, vol.
281, no. 32, pp. 22974–22982, 2006.
[10] K. R. Bridle, T. K. Cheung, T. L. Murphy et al., “Hepcidin
is down-regulated in alcoholic liver injury: implications for
thepathogenesisofalcoholicliverdisease,”Alcoholism:Clinical
and Experimental Research, vol. 30, no. 1, pp. 106–112, 2006.
[11] T. Ohtake, H. Saito, Y. Hosoki et al., “Hepcidin is down-
regulated in alcohol loading,” Alcoholism: Clinical and Experi-
mental Research, vol. 31, no. 1, pp. S2–S8, 2007.
[12] D. D. Harrison-Findik, E. Klein, C. Crist, J. Evans, N.
Timchenko, and J. Gollan, “Iron-mediated regulation of liver
hepcidin expression in rats and mice is abolished by alcohol,”
Hepatology, vol. 46, no. 6, pp. 1979–1985, 2007.
[13] J. M. Flanagan, H. Peng, and E. Beutler, “Eﬀects of alcohol
consumption on iron metabolism in mice with hemochro-
matosis mutations,” Alcoholism: Clinical and Experimental
Research, vol. 31, no. 1, pp. 138–143, 2007.
[14] C. Pigeon, G. Ilyin, B. Courselaud et al., “A new mouse
liver-speciﬁc gene, encoding a protein homologous to human
antimicrobial peptide hepcidin, is overexpressed during iron
overload,” Journal of Biological Chemistry, vol. 276, no. 11, pp.
7811–7819, 2001.
[15] C. H. Park, E. V. Valore, A. J. Waring, and T. Ganz, “Hepcidin,
a urinary antimicrobial peptide synthesized in the liver,”
Journal of Biological Chemistry, vol. 276, no. 11, pp. 7806–
7810, 2001.
[16] G.Nicolas,L.Viatte,M.Bennoun,C.Beaumont,A.Kahn,and
S. Vaulont, “Hepcidin, a new iron regulatory peptide,” Blood
Cells, Molecules & Diseases, vol. 29, no. 3, pp. 327–335, 2002.
[17] E. Nemeth, M. S. Tuttle, J. Powelson et al., “Hepcidin
regulates iron eﬄux by binding to ferroportin and inducing
its internalization,” Science, vol. 306, no. 5704, pp. 2090–2093,
2004.
[18] D. M. Kingsley, “The TGF-β superfamily: new members,
new receptors, and new genetic tests of function in diﬀerent
organisms,”GenesandDevelopment,vol.8,no.2,pp.133–146,
1994.
[19] L. Lin, E. V. Valore, E. Nemeth, J. B. Goodnough, V. Gabayan,
and T. Ganz, “Iron transferrin regulates hepcidin synthesis
in primary hepatocyte culture through hemojuvelin and
BMP2/4,” Blood, vol. 110, no. 6, pp. 2182–2189, 2007.
[20] J. Truksa, H. Peng, P. Lee, and E. Beutler, “Bone morpho-
genetic proteins 2, 4, and 9 stimulate murine hepcidin 1
expressionindependentlyofHfe,transferrinreceptor2(Tfr2),
and IL-6,” Proceedings of the National Academy of Sciences of
theUnitedStatesofAmerica,vol.103,no.27,pp.10289–10293,
2006.
[21] J.L.Babitt,F.W.Huang,Y.Xia,Y.Sidis,N.C.Andrews,andH.
Y. Lin, “Modulation of bone morphogenetic protein signaling
in vivo regulates systemic iron balance,” Journal of Clinical
Investigation, vol. 117, no. 7, pp. 1933–1939, 2007.
[22] J. L. Babitt, F. W. Huang, D. M. Wrighting et al., “Bone
morphogenetic protein signaling by hemojuvelin regulates
hepcidin expression,” Nature Genetics, vol. 38, no. 5, pp. 531–
539, 2006.
[23] B. Andriopoulos, E. Corradini Jr., Y. Xia et al., “BMP6 is a
key endogenous regulator of hepcidin expression and iron
metabolism,” Nature Genetics, vol. 41, no. 4, pp. 482–487,
2009.
[24] D. Meynard, L. Kautz, V. Darnaud, F. Canonne-Hergaux, H.
Coppin, and M. P. Roth, “Lack of the bone morphogenetic
protein BMP6 induces massive iron overload,” Nature Genet-
ics, vol. 41, no. 4, pp. 478–481, 2009.
[25] L. Kautz, D. Meynard, A. Monnier et al., “Iron regulates
phosphorylation of Smad1/5/8 and gene expression of Bmp6,
Smad7, Id1, and Atoh8 in the mouse liver,” Blood, vol. 112, no.
4, pp. 1503–1509, 2008.International Journal of Hepatology 11
[26] S. Arndt, U. Maegdefrau, C. Dorn, K. Schardt, C. Hellerbrand,
a n dA .K .B o s s e r h o ﬀ, “Iron-induced expression of bone
morphogenic protein 6 in intestinal cells is the main regulator
of hepatic hepcidin expression in vivo,” Gastroenterology, vol.
138, no. 1, pp. 372–382, 2010.
[27] L. Kautz, C. Besson-Fournier, D. Meynard, C. Latour, and M.
P. Roth, “Iron overload induces BMP6 expression in the liver
but not in the duodenum,” Haematologica, vol. 96, pp. 199–
203, 2011.
[ 2 8 ]D .C h e n ,M .Z h a o ,a n dG .R .M u n d y ,“ B o n em o r p h o g e n e t i c
proteins,” Growth Factors, vol. 22, no. 4, pp. 233–241, 2004.
[29] J. Massague, J. Seoane, and D. Wotton, “Smad transcription
factors,” Genes and Development, vol. 19, no. 23, pp. 2783–
2810, 2005.
[30] E. Piek, C. H. Heldin, and P. T. Dijke, “Speciﬁcity, diversity,
and regulation in TGF-β superfamily signaling,” FASEB Jour-
nal, vol. 13, no. 15, pp. 2105–2124, 1999.
[31] C. H. Heldin, K. Miyazono, and P. Ten Dijke, “TGF-β
signalling from cell membrane to nucleus through SMAD
proteins,” Nature, vol. 390, no. 6659, pp. 465–471, 1997.
[32] R. H. Wang, C. Li, X. Xu et al., “A role of SMAD4 in
iron metabolism through the positive regulation of hepcidin
expression,” Cell Metabolism, vol. 2, no. 6, pp. 399–409, 2005.
[33] S. V. Siegmund, S. Dooley, and D. A. Brenner, “Molecular
mechanisms of alcohol-induced hepatic ﬁbrosis,” Digestive
Diseases, vol. 23, no. 3-4, pp. 264–274, 2006.
[34] C. Meyer, N. M. Meindl-Beinker, and S. Dooley, “TGF-
beta signaling in alcohol induced hepatic injury,” Frontiers in
Bioscience, vol. 15, pp. 740–749, 2010.
[35] P. Coyle, J. C. Philcox, and A. M. Rofe, “Metallothionein-null
mice absorb less Zn from an egg-white diet, but a similar
amount from solutions, although with altered intertissue Zn
distribution,”JournalofNutrition,vol.129,no.2,pp.372–379,
1999.
[36] D. D. Harrison-Findik, E. Klein, J. Evans, and J. Gollan, “Reg-
ulation of liver hepcidin expression by alcohol in vivo does
not involve Kupﬀer cell activation or TNF-alpha signaling,”
TheAmericanJournalofPhysiology—GastrointestinalandLiver
Physiology, vol. 296, pp. G112–G118, 2009.
[37] A. S. Weinmann, S. M. Bartley, T. Zhang, M. Q. Zhang, and P.
J. Farnham, “Use of chromatin immunoprecipitation to clone
novel E2F target promoters,” Molecular and Cellular Biology,
vol. 21, no. 20, pp. 6820–6832, 2001.
[38] K. Breitkopf, S. Haas, E. Wiercinska, M. V. Singer, and S.
Dooley, “Anti-TGF-β strategies for the treatment of chronic
liver disease,” Alcoholism: Clinical and Experimental Research,
vol. 29, no. 11, pp. 121S–131S, 2005.
[39] D. D. Harrison-Findik, “Role of alcohol in the regulation of
iron metabolism,” World Journal of Gastroenterology, vol. 13,
no. 37, pp. 4925–4930, 2007.
[40] T. B. Chaston, P. Matak, K. Pourvali, S. K. Srai, A. T.
McKie,andP.A.Sharp,“Hypoxiainhibitshepcidinexpression
in HuH7 hepatoma cells via decreased SMAD4 signaling,”
American Journal of Physiology—Cell Physiology, vol. 300, no.
4, pp. C888–C895, 2011.
[41] X. Wu, M. S. Chang, S. A. Mitsialis, and S. Kourembanas,
“Hypoxia regulates bone morphogenetic protein signaling
through C-terminal-binding protein 1,” Circulation Research,
vol. 99, no. 3, pp. 240–247, 2006.
[42] S. W. French, N. C. Benson, and P. S. Sun, “Centrilobular
liver necrosis induced by hypoxia in chronic ethanol-fed rats,”
Hepatology, vol. 4, no. 5, pp. 912–917, 1984.
[43] N. Dumont and C. L. Arteaga, “A kinase-inactive type II TGF-
beta receptor impairs BMP signaling in human breast cancer
cells,” Biochemical and Biophysical Research Communications,
vol. 301, pp. 108–112, 2003.
[44] J. D. Yan, S. Yang, J. Zhang, and T. H. Zhu, “BMP6 reverses
TGF-β1-induced changes in HK-2 cells: implications for the
treatment of renal ﬁbrosis,” Acta Pharmacologica Sinica, vol.
30, no. 7, pp. 994–1000, 2009.
[45] A. I. Cederbaum, “Role of lipid peroxidation and oxidative
stress in alcohol toxicity,” Free Radical Biology and Medicine,
vol. 7, no. 5, pp. 537–539, 1989.
[46] H. Tsukamoto, Y. Takei, C. J. McClain et al., “How is the liver
primed or sensitized for alcoholic liver disease?” Alcoholism:
Clinical and Experimental Research, vol. 25, no. 5, pp. 171S–
181S, 2001.
[47] S. Wang and R. Hirschberg, “BMP7 antagonizes TGF-β-
dependent ﬁbrogenesis in mesangial cells,” The American
Journal of Physiology, vol. 284, no. 5, pp. F1006–F1013, 2003.
[48] G. M. Mitu, S. Wang, and R. Hirschberg, “BMP7 is a podocyte
survival factor and rescues podocytes from diabetic injury,”
The American Journal of Physiology—Renal Physiology, vol.
293, no. 5, pp. F1641–F1648, 2007.
[49] E. Fransvea, U. Angelotti, S. Antonaci, and G. Giannelli,
“Blocking transforming growth factor-beta up-regulates E-
cadherinandreducesmigrationandinvasionofhepatocellular
carcinoma cells,” Hepatology, vol. 47, no. 5, pp. 1557–1566,
2008.
[50] S. Yang, J. Du, Z. Wang et al., “BMP-6 promotes E-cadherin
expression through repressing δEF1 in breast cancer cells,”
BMC Cancer, vol. 7, article 211, 2007.
[51] H. Tsukamoto, W. Horne, S. Kamimura et al., “Experimental
liver cirrhosis induced by alcohol and iron,” Journal of Clinical
Investigation, vol. 96, no. 1, pp. 620–630, 1995.
[52] A. I. Cederbaum, “Iron and CYP2E1-dependent oxidative
stress and toxicity,” Alcohol, vol. 30, no. 2, pp. 115–120, 2003.
[53] L. M. Fletcher and L. W. Powell, “Hemochromatosis and
alcoholic liver disease,” Alcohol, vol. 30, no. 2, pp. 131–136,
2003.
[54] E. Corradini, C. Garuti, G. Montosi et al., “Bone morpho-
genetic protein signaling is impaired in an HFE knockout
mouse model of hemochromatosis,” Gastroenterology, vol.
137, no. 4, pp. 1489–1497, 2009.
[55] L. Kautz, D. Meynard, C. Besson-Fournier et al., “BMP/Smad
signaling is not enhanced in Hfe-deﬁcient mice despite
increased Bmp6 expression,” Blood, vol. 114, no. 12, pp. 2515–
2520, 2009.